Enzon Pharmaceuticals Inc
Article Abstract:
NPS P harmaceticals plans to acquire Enzon Pharmaceuticals Inc. and the merger is expected to result in a stronger combined company. Stock is unran ked due to t he pending acquisition.
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2003
Biotechnology industry, Biotechnology industries
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2003
User Contributions:
Comment about this article or add new information about this topic:
NPS Pharma Inc
Article Abstract:
NPS Pharmaceuticals Inc. plans to acquire Enzon Pharmaceuticals Inc. and is expected to increase revenues out to 2006-2008. Investors are advised to hold off any commitments for now.
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2003
Strategy & planning, Planning, Company business planning, NPS Pharmaceuticals Inc., NPSP
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2003
User Contributions:
Comment about this article or add new information about this topic:
Subjects list: United States, Pharmaceutical industry, Mergers, acquisitions and divestments, Finance, Company acquisition/merger, Company investment, Investments, Statistics, Securities, Company sales and earnings, Company earnings/profit, Company securities, Company business forecast/projection, Company forecasts, Enzon Pharmaceuticals Inc.
Similar abstracts:
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.